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TO THE EDITOR
Hidradenitis suppurativa (HS; OMIM
142690) is a chronic skin disease
observed in 1% of the population and
characterized by recurrent, deep ab-
scesses located in the axillae, inguinal
folds, and the buttocks. This affection is
responsible for a very poor quality of
life in the most severe patients. At least
one-third of patients show an autoso-
mal dominant inheritance (Fitzsimmons
and Guilbert, 1985). Within the past
few months, four reports involved g-
secretase mutations in familial HS
(Wang et al., 2010; Li et al., 2011; Liu
et al., 2011; Pink et al., 2011).
g-Secretase is a transmembrane en-
zymatic complex that is composed of
Presenilin (catalytic subunit), encoded
by two homologs (PSEN1 and PSEN2),
and three cofactors: Presenilin En-
hancer 2 (PSENEN), Nicastrin (NCSTN),
and Anterior Pharynx Defective-1,
which also has two homologs (APH1A
and APH1B). It catalyzes the cleavage
of a wide range of transmembrane
proteins, including b-amyloid precursor
and Notch, which have generated a
great interest because of their involve-
ment in Alzheimer’s disease and crucial
developmental pathways, respectively
(Shirotani et al., 2004).
Herein we report the identification of
Nicastrin mutations, which to our
knowledge were not previously re-
ported, in 3 out of 14 families of French
origin with HS. A total of 104 individuals
were recruited for this genetic study and
signed a written informed consent.
Diagnosis was confirmed according to
Von Der Werth criteria (Von Der Werth
et al., 2000). The study complies with
the principles of the Declaration of
Helsinki Principles and was approved
by the local ethics committee.
All affected members were non-
obese and have been afflicted with HS
since puberty. The patients of family 1
presented large hypertrophic scars
and fistulas in the axillary, inguinal,
and perianal folds with no spared area
(Figures 2a and b). In families 2 and 3,
the disease was less severe with inter-
vals of normal skin in the same in-
volved areas (Figures 2c–e). Associated
diseases in affected members of these
pedigrees included acne conglobata in
pedigrees 1 and 2. Two affected mem-
bers of pedigree 3 developed pelvis-
pondylitis HLA B27(-), and one of them
suffered from Crohn’s disease.
Genomic DNA was extracted from
venous blood or saliva. After having
excluded PSEN1, PSENEN, NCSTN,
and APH1A loci in two families by
haplotype analysis, we proceeded to
direct sequencing of the six g-secretase
genes in one affected individual from
each of the remaining families (see
Supplementary Text and Table S1 online).
We also sequenced PSEN2 and APH1B
in the two excluded families.
In family 1, sequence analysis of
g-secretase genes revealed a nonsense
mutation (c.1300C4T; GenBank acces-
sion NM_015331.2), which results in a
premature termination codon in exon 11
of NCSTN (p.Arg434X; Figure 1a).
In the proband of family 2, we iden-
tified a heterozygous single-base dele-
tion in exon 5 of NCSTN (c.487delC)
leading to a frameshift and a premature
termination codon (p.Gln163SerfsX39;
Figure 1b).
In family 3, we found a heterozygous
base-pair substitution (c.1768A4G) in
exon 15 of NCSTN (Figure 1c). Inter-
estingly, sequencing of cloned reverse-
transcriptase–PCR products from
peripheral blood mononuclear cells of
one affected individual revealed that
this A4G transition causes abnormal
splicing, generating two aberrant tran-
scripts in addition to the wild-type
transcript arising from the nonmu-
tated allele (Supplementary Figure S1
online). The first aberrant transcript
resulted from the use of a cryptic
splice-donor site located immediately
downstream of the mutation leading to
the deletion of the last 26 nucleotides of
exon 15 and a premature termination
codon (p.Ser590AlafsX3). The second
aberrant transcript is spliced using
the same cryptic splice-donor site in
exon 15, and a newly activated cryptic
splice-acceptor site within exon 16.
This splicing event removed the last
26 nucleotides of exon 15 and the
first 88 nucleotides of exon 16, resulting
in an in-frame deletion of 114 nucleo-
tides (Figure 2f). We found no evidence
for normally spiced mutated allele.
Quantitative real-time reverse-
transcriptase–PCR analysis showed a
significant reduction of transcript levels
of NCSTN in the patient of family 2
compared with controls, indicating
that the mutant transcripts are subject
to nonsense-mediated decay. In con-
trast, we did not observe reduction of
NCSTN transcript levels in families 1
and 3 (data not shown).
In each family, these heterozygous
mutations segregated with the disease
phenotype and were not observed in
100 French control individuals. They
were present neither in the dbSNP135
nor in the 1,000 genomes project.
Nicastrin is a glycoprotein acting
as a g-secretase complex stabilizer
(Zhao et al., 2010). It is, to date, the
most frequently mutated gene among
the g-secretase subunits in familial HS
cases. In this study, mutations in
NCSTN were identified in 3 out of 14
pedigrees only, indicating the implica-
tion of other genes or the existence of
causative mutations in noncoding re-
gions of the known g-secretase genes in
these families.
The frameshift mutation in family 2
leads to haploinsufficiency, consideringAbbreviations: HS, hidradenitis suppurativa
1728 Journal of Investigative Dermatology (2012), Volume 132
S Miskinyte et al.
Novel NCSTN Mutations in HS
the severe reduction of NCSTN tran-
script levels in the patient. In families
1 and 3, the mutations may result in
unstable proteins, leading to haplo-
insufficiency. It is also possible that
the truncated protein in family 1 and
the protein carrying the D26 deletion in
family 3 are stable enough but fail to
form the g-secretase complex because
they lack the transmembrane domain
by which Nicastrin interacts with the
other components of the complex
(Capell et al., 2003). Should the D114
mutated protein in family 3 be stable,
we presume that it could fail in the
correct folding required for the assem-
bly and function of the g-secretase
complex (Shirotani et al., 2003).
The pathophysiological mechanisms
of HS remain unclear; however, several
lines of evidence indicate that the
Notch signaling pathway is likely to
be involved. Indeed, Notch 1, 2, and
3 knockout mice develop a cutaneous
phenotype that mimics the g-secretase
knockout phenotype, including cyst
formation, and epidermal and hair
follicle defects (Pan et al., 2004). In
addition, disruption of the nuclear target
of Notch, RBP-J, also leads to epidermal
cyst formation (Yamamoto et al., 2003),
a common hallmark in HS patients.
These observations are consistent with
a role of defective Notch signaling in HS
and suggest that genes of the Notch
pathway could be potential new candi-
date genes for this condition.
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Figure 1. Sequencing chromatograms showing NCSTN mutations detected in the three French families
affected with hidradenitis suppurativa. (a) Wild-type sequence and nonsense mutation (c.1300C4T;
p.Arg434X) in pedigree 1. PTC, premature termination codon (TGA). (b) Wild-type sequence and single-
nucleotide deletion (c.487delC; p.Gln163SerfsX39) in pedigree 2. Amino acids resulting from this
frameshift mutation are highlighted in red. (c) Wild-type sequence and single-nucleotide substitution
(c.1768A4G), which affects NCSTN pre-mRNA splicing in pedigree 3.
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TO THE EDITOR
Generalized vitiligo (GV) is a common
autoimmune disease resulting from
the destruction of melanocytes in the
involved areas, epidemiologically asso-
ciated with elevated prevalence of
certain other autoimmune diseases
(Picardo and Taı¨eb, 2010). In a
recent genome-wide association study
(GWAS) of GV, carried out in Euro-
pean-derived whites (EUR), we identi-
fied 16 loci that contribute to GV risk
(Jin et al., 2010a,b; Birlea et al., 2011).
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Figure 2. Genealogical trees, skin lesions in families 1 and 2, and differently spliced transcripts of NCSTN
in family 3. ‘‘þ ’’ Indicates family members who were examined and sequenced. (a) Pedigree 1; (b)
hypertrophic scars and nodules of the groin. (c) Pedigree 2; (d) hypertrophic scars and fistulas of the buttocks.
(e) Pedigree 3; (f) three different transcripts were identified in the proband of family 3: a wild-type transcript
(WT) and two transcripts derived from the c.1768A4G mutation: D26, resulting from a 26-bp deletion of
exon 15 and D114, harboring a 26-bp deletion of exon 15 and an 88-bp deletion of exon 16. Newly
activated acceptor (AG) and donor (GT) cryptic slice sites are highlighted in blue.
Abbreviations: EUR, European-derived whites; GV, generalized vitiligo; GWAS, genome-wide
association study; MHC, major histocompatibility complex; OCA1, oculocutaneous albinism type 1;
OR, odds ratio; SNP, single-nucleotide polymorphism; TYR, tyrosinase (gene or protein)
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